AN1901: Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS Glucagon-like peptide-1 analogs (GLP-1a), such as liraglutide and semaglutide, represent one of the fastest-growing classes of therapies, with seven FDA-approved treatments and over 50 currently in clinical trials as of 2024
In Phase 2 trials involving 338 participants across all doses, 88.8% of patients at the 12mg dose successfully completed the 48-week study despite experiencing side effects
Atopic dermatitis, commonly referred to as eczema, is an inflammatory skin condition that typically starts early in life
Ariel Soffer and our team at Soffer Health Institute are all too familiar with the incredibly long list of health and wellness issues that stem from carrying excess weight, and we want to help
As well, plasma homocysteine level predicts the clinical outcomes in PD patients (Zhong et al